These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23958960)

  • 21. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
    Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety.
    Nummenmaa L; Karjalainen T; Isojärvi J; Kantonen T; Tuisku J; Kaasinen V; Joutsa J; Nuutila P; Kalliokoski K; Hirvonen J; Hietala J; Rinne J
    Neuropsychopharmacology; 2020 Oct; 45(11):1953-1959. PubMed ID: 32473595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.
    Ghitza UE; Preston KL; Epstein DH; Kuwabara H; Endres CJ; Bencherif B; Boyd SJ; Copersino ML; Frost JJ; Gorelick DA
    Biol Psychiatry; 2010 Oct; 68(8):697-703. PubMed ID: 20579973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of regional endogenous opioid function in borderline personality disorder.
    Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR
    Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers.
    Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK
    Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust age, but limited sex, differences in mu-opioid receptors in the rat brain: relevance for reward and drug-seeking behaviors in juveniles.
    Smith CJW; Ratnaseelan AM; Veenema AH
    Brain Struct Funct; 2018 Jan; 223(1):475-488. PubMed ID: 28871491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
    Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
    Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social Laughter Triggers Endogenous Opioid Release in Humans.
    Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L
    J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mu-opioid receptor system modulates responses to vocal bonding and distress signals in humans.
    Sun L; Lukkarinen L; Putkinen V; Karlsson HK; Hirvonen J; Tiihonen J; Lauerma H; Scott S; Nummenmaa L
    Philos Trans R Soc Lond B Biol Sci; 2022 Nov; 377(1863):20210181. PubMed ID: 36126675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.
    Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE
    Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.
    Karlsson HK; Tuominen L; Tuulari JJ; Hirvonen J; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L
    J Neurosci; 2015 Mar; 35(9):3959-65. PubMed ID: 25740524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys.
    Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL
    J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. µ-opioid receptor-mediated downregulation of midline thalamic pathways to basal and central amygdala.
    Goedecke L; Bengoetxea X; Blaesse P; Pape HC; Jüngling K
    Sci Rep; 2019 Nov; 9(1):17837. PubMed ID: 31780740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.